|
BCOR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.357800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.072200E-01 |
| Normal-vs-Stage2 |
6.677200E-01 |
| Normal-vs-Stage3 |
2.041600E-02 |
| Normal-vs-Stage4 |
2.569900E-04 |
| Stage1-vs-Stage2 |
5.234600E-01 |
| Stage1-vs-Stage3 |
1.478820E-01 |
| Stage1-vs-Stage4 |
1.464230E-03 |
| Stage2-vs-Stage3 |
1.182650E-01 |
| Stage2-vs-Stage4 |
9.158300E-03 |
| Stage3-vs-Stage4 |
1.150010E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.168400E-02 |
| Normal-vs-AfricanAmerican |
8.960600E-01 |
| Normal-vs-Asian |
1.381380E-01 |
| Caucasian-vs-AfricanAmerican |
2.426600E-01 |
| Caucasian-vs-Asian |
8.341200E-01 |
| AfricanAmerican-vs-Asian |
4.313000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.483600E-02 |
| Normal-vs-Female |
1.048830E-01 |
| Male-vs-Female |
7.140400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.190000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.864300E-02 |
| Normal-vs-Age(61-80Yrs) |
4.524200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.710000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.714400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.217600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.471600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.352000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.395800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.279200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.63860000000194E-05 |
| Classical-VS-Follicular |
8.194000E-01 |
| Classical-VS-Other |
7.212800E-01 |
| Classical-VS-Normal |
2.228600E-01 |
| Tall-VS-Follicular |
3.770200E-04 |
| Tall-VS-Other |
1.144810E-01 |
| Tall-VS-Normal |
5.97580000000208E-05 |
| Follicular-VS-Other |
6.937200E-01 |
| Follicular-VS-Normal |
3.890800E-01 |
| Other-VS-Normal |
3.545800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.914410E-01 |
| Normal-vs-N1 |
6.011400E-04 |
| N0-vs-N1 |
4.502000E-03 |
|
|
